ArticlePathology oncology research : POR2020

In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.

Andrea Angelo Pierluigi Tripodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.